Methotrexate is an antimetabolite and antifolate agent with antineoplastic and immunosuppressant activities.

Mildronate is an inhibitor of biosynthesis of L-carnitine by gamma-butyrobetaine (GBB) hydroxylase and as a competitive inhibitor of renal carnitine reabsorption.

Brinzolamide is a sulfonamide and carbonic anhydrase inhibitor with specific affinity for carbonic anhydrase II.

Vidofludimus is an orally active and potent dihydroorotate dehydrogenase (DHODH) inhibitor.

Anacetrapib is a cholesteryl ester transfer protein (CETP) inhibitor with hypocholesterolemic properties.

Oxaprozin is a nonsteroidal anti-inflammatory drug (NSAID) derivative of oxazole-propionic acid with analgesic and antipyretic properties.

Ozagrel is a selective thromboxane A(2) (TXA(2)) synthetase inhibitor.

Ozagrel sodium is a selective thromboxane A(2) (TXA(2)) synthetase inhibitor.